Table 1.
Category | All (2589)* | No Fatty Liver (2150)* | Fatty Liver (439)* | p-value# |
---|---|---|---|---|
Covariates | ||||
Female (%) | 51 | 44 | 53 | 0.0002 |
Age (years) | 51.0(10.6) | 50.8(10.6) | 52.3(10.7) | 0.0015 |
Drinks per week | 3.0(3.5) | 3.0(3.4) | 3.1(3.9) | 0.7619 |
Physical Activity | 37.4(6.8) | 37.5(6.9) | 36.9(6.4) | 0.0256 |
Smoking Category | 0.1376 | |||
Smoke Never (%) | 49.7 (1287) | 50.6 (1088) | 45.3 (199) | |
Smoke Former (%) | 38.7 (1002) | 37.9 (815) | 42.6 (137) | |
Smoke Current (%) | 11.6 (300) | 11.5 (247) | 12.1 (53) | |
Education Category | 0.0028 | |||
Education some High School (%) | 1.6 (41) | 1.5 (32) | 2.5 (11) | |
Education High School Graduate | 21.3 (551) | 20.7 (445) | 24.3 (107) | |
Education Some College (%) | 29.7 (769) | 29.0 (624) | 32.9 (144) | |
Education College Graduate (%) | 47.4 (1227) | 48.8 (1049) | 40.3 (177) | |
Menopause (women only) (%) | 26.1 (676) | 26.1 (561) | 26.2 (115) | 0.0623 |
HRT (%) | 11.9 (308) | 11.8 (254) | 12.5 (55) | 0.1872 |
Fat related | ||||
BMI (kg/m2) | 27.6(5.3) | 26.8(4.8) | 31.4(5.8) | <.0001 |
Waist Circumference (cm) | 96.5(14.3) | 94.4(13.4) | 106.4(14.1) | <.0001 |
Subcutaneous Adipose Tissue (cm3) | 2847.7(1399.0) | 2697.5(1327.1) | 3583.4(1506.4) | <.0001 |
Visceral Adipose Tissue (cm3) | 1749.5(1021.4) | 1568.1(912.9) | 2638.1(1059.6) | <.0001 |
BMI Category | <.0001 | |||
Normal weight (BMI<25) | 34.0 (882) | 38.9 (837) | 10.3 (45) | |
Overweight (25<=BMI<30) | 39.5 (1022) | 40.4(869) | 34.9 (153) | |
Obese (BMI>=30) | 26.5 (685) | 20.7 (444) | 54.9 (241) | |
Glucose related | ||||
Fasting Glucose (mg/dl) | 99.1 (12.9) | 97.1 (19.4) | 108.7 (33.6) | <.0001 |
Diabetes Mellitus (%) | 6.7 (173) | 5.1 (110) | 14.6 (64) | <.0001 |
IFG-Non-DM Only(%) | 27.5 (712) | 23.6 (507) | 48.8 (214) | <.0001 |
HOMA-IR [Median (Q1–Q3)] | 2.63 (2.11 – 3.54) | 2.47 (2.05 – 3.21) | 3.88 (2.95 – 5.39) | <.0001 |
log HOMA-IR | 1.03 (0.47) | 0.95 (0.43) | 1.40 (0.51) | <.0001 |
Insulin resistance (%) | 28.9(692) | 21.6(425) | 62.7(267) | <.0001 |
Adiponectin (μg/ml)** | 9.8(6.0) | 10.5(6.1) | 7.0(4.8) | <.0001 |
Resistin [Median (Q1–Q3)] | 13.40 (10.60 – 17.10) | 13.25 (10.40 – 17.05) | 14.20 (11.80 – 17.70) | 0.0474 |
log Resistin (ng/ml)** | 2.62 (0.41) | 2.61 (0.41) | 2.67 (0.39) | 0.1199 |
Lipid related | ||||
Triglycerides (mg/dL) | 103[71–155] | 95[67–139] | 157[110–217] | <.0001 |
HDL Cholesterol (mg/dl) | 52.5(15.8) | 54.0(15.7) | 45.2(14.1) | <.0001 |
Total Cholesterol (mg/dL) | 195.2(35.4) | 194.6(35.0) | 197.9(37.1) | 0.1065 |
Blood pressure related | ||||
SBP (mmHg) | 121.1 (16.2) | 120.0(16.1) | 126.8(15.3) | <.0001 |
DBP (mmHg) | 75.28(9.3) | 74.7(9.1) | 78.1 (9.5) | <.0001 |
Hypertension (%) | 27.3 (707) | 23.6 (507) | 45.4 (199) | <.0001 |
Syndrome related | ||||
Metabolic Syndrome (%) | 31.4 (813) | 25.0 (538) | 62.9 (276) | <.0001 |
data in parentheses refers to the standard deviation for continuous traits and the number affected for dichotomous traits
represents mean (SD) or median(inter quartile range) or percent (number of individuals)
based on t-test or Wilcoxon Rank Sum Test or Chi squared
based on 857 individuals in offspring only, 157 with fatty liver and 700 without fatty liver
HRT: hormone replacement therapy
BMI: Body mass index
IFG: impaired fasting glucose
HOMA-IR: Homeostasis model assessment of insulin resistance
HDL: high density lipoprotein
SBP: systolic blood pressure